APA (7th ed.) Citation

Mazzone, E., Gandaglia, G., Robesti, D., Rajwa, P., Gomez Rivas, J., Ibáñez, L., . . . Briganti, A. (2024). Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters. European urology oncology, 7(2), 231-240. https://doi.org/10.1016/j.euo.2023.08.010

Chicago Style (17th ed.) Citation

Mazzone, Elio, et al. "Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters." European Urology Oncology 7, no. 2 (2024): 231-240. https://doi.org/10.1016/j.euo.2023.08.010.

MLA (9th ed.) Citation

Mazzone, Elio, et al. "Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters." European Urology Oncology, vol. 7, no. 2, 2024, pp. 231-240, https://doi.org/10.1016/j.euo.2023.08.010.